Atopic Dermatitis Epidemiology Forecast 2026-2035

Atopic dermatitis (AD) is a highly prevalent chronic inflammatory skin disorder worldwide. According to Suzanne Heather Keddie et al., 2025, AD affects approximately 204 million people globally and ranks 15th among non-fatal diseases, representing one the leading skin disease by disability-adjusted life-years. As per the atopic dermatitis epidemiology forecast, the disease burden continues to rise due to increasing diagnoses and awareness.

Atopic Dermatitis Epidemiology Forecast Report Coverage

The analyst's “Atopic Dermatitis Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of atopic dermatitis. It projects the future incidence and prevalence rates of atopic dermatitis cases across various populations. The study covers age, gender, and type as major determinants of the atopic dermatitis population. The report highlights patterns in the prevalence of atopic dermatitis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of atopic dermatitis in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Atopic Dermatitis Understanding: Disease Overview

Atopic dermatitis is a chronic inflammatory skin disorder characterized by intense itching, dryness, redness, and recurrent eczematous lesions. It occurs due to a combination of genetic predisposition, impaired skin barrier function, immune dysregulation, and environmental triggers such as allergens, irritants, and microbial exposure. The condition commonly begins in infancy or early childhood but can persist into adulthood. Dysfunction of the epidermal barrier allows allergens and pathogens to penetrate the skin, triggering inflammation. Major clinical forms include acute atopic dermatitis with erythematous and oozing lesions, subacute dermatitis with scaling, and chronic atopic dermatitis characterized by thickened, lichenified skin lesions.

Atopic Dermatitis Epidemiology Perspective

The atopic dermatitis epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the atopic dermatitis epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for atopic dermatitis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Jack Jeskey et al., 2024, atopic dermatitis affects approximately 220 million people worldwide and remains one of the most common chronic inflammatory skin diseases, with prevalence reaching up to 20% in children and around 10% in adults, highlighting its substantial global disease burden.
• According to Aleksandr Aravkin et al., 2025, global cases of atopic dermatitis increased from 107 million in 1990 to about 129 million in 2021, while the age-standardized prevalence declined by approximately 8.3%, indicating population growth as a major contributor to the increasing number of cases.
• According to Kaitlyn R. Chan et al., 2026, the prevalence of atopic dermatitis in the United States was 7.3% among adults and 10.7% among children in 2021, rising to 7.6% in adults and 12.7% in children in 2024, with a statistically significant increase observed among children.
• According to Siri Choragudi et al., 2023, analysis of the National Health Interview Survey (1997-2018) involving 260,888 children aged 0-17 years showed eczema prevalence increasing from 7.9% in 1997 to 12.6% in 2018, before stabilizing after 2010 across most demographic subgroups.
• According to Kaitlyn R. Chan et al., 2026, epidemiological data also indicate demographic variation, with adult populations showing a slightly higher proportion of females, while male participants were more common among children, alongside mean ages of 48.4 years for adults and 8.8 years for children in 2024.

Country-wise Atopic Dermatitis Epidemiology

The atopic dermatitis epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Across major healthcare markets, the epidemiology of atopic dermatitis demonstrates notable regional variation. According to Patel’s Chemist Limited, approximately one in five children and one in ten adults in the United Kingdom are affected by eczema. As per Abdulelah Alghamdi et al., 2025, the 12-month prevalence of atopic dermatitis is about 4.9% in the United States and 4.4% across the European Union, with country-specific estimates of 8.1% in Italy, 2.2% in Germany, and higher prevalence also reported in Spain and southern Europe. The prevalence is approximately 2.1% in Japan. In India, according to Abhishek De et al., 2023, reported prevalence ranges from 3.1%-7.21% among children and 0.98%-9.2% across combined pediatrics and adult populations, highlighting regional epidemiological diversity.

Atopic Dermatitis: Treatment Overview

Management of atopic dermatitis focuses on reducing inflammation, relieving itching, restoring the skin barrier, and preventing disease flares. First-line therapy includes regular use of emollients and moisturizers to maintain skin hydration, along with topical corticosteroids and topical calcineurin inhibitors for inflammatory control. In moderate-to-severe cases, systemic therapies such as immunosuppressants or biologic agents may be prescribed. Targeted biologics, including dupilumab, inhibit inflammatory pathways involved in the disease. Additional approaches include phototherapy, antihistamines for itch relief, and avoidance of known triggers to support long-term disease management.

Key Questions Answered

• What are the key findings of atopic dermatitis epidemiology in the 8 major markets?
• What will be the total number of patients with atopic dermatitis across the 8 major markets during the forecast period?
• What was the country-wise atopic dermatitis epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of atopic dermatitis patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population atopic dermatitis during the forecast period of 2026-2035?
• What are the currently available treatments for atopic dermatitis?
• What are the disease risks, signs, symptoms, and unmet needs of atopic dermatitis?

Scope of the Atopic Dermatitis Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of atopic dermatitis based on several factors.
• Atopic Dermatitis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The atopic dermatitis report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.